Literature DB >> 9856862

Pregnenolone sulfate modulates NMDA receptors, inducing and potentiating acute excitotoxicity in isolated retina.

P Guarneri1, D Russo, C Cascio, G De Leo, T Piccoli, V Sciuto, F Piccoli, R Guarneri.   

Abstract

Pregnenolone sulfate (PS) acts as a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor-mediated responses. In the retina, we previously observed that the synthesis of pregnenolone and PS increases after stimulation of NMDA receptors and blockade of the synthesis reduces retinal cell death. This study was carried out to explore in the isolated and intact retina the possible role of PS in NMDA-induced excitotoxicity. Lactate dehydrogenase (LDH) measurements and morphological analysis revealed that a 90-min exogenous application of PS at 0.1-500 microM concentrations potentiated NMDA-induced cell death and at 50-500 microM concentrations caused cytotoxicity. After 45 min, either NMDA or PS caused no significant LDH release; but their co-application resulted in a high degree of toxicity. In addition, we found that a mild NMDA insult developed into serious damage when even low PS concentrations (0.1-10 microM) were used. Toxicity-inducing and -potentiating effects were specific to PS modulatory action on NMDA receptors, in that they were blocked by 4-(3-phosphonopropyl)2-piperazinecarboxylic acid (CPP) and MK-801 but not by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and neither dehydroepiandrosterone sulfate nor pregnenolone caused LDH release. Prevention of degenerative signs was seen in retinae pretreated with 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), a Cl- channel blocker, thus indicating a Na+/Cl--dependent acute mode of excitotoxic cell death responsible for PS toxicity. The positive interaction between the neurosteroid and NMDA receptors was further proved by a PS dose-dependent increase in NMDA-induced stimulation of [3H] MK-801 binding to retinal membranes. The results suggest a crucial role of PS in retinal vulnerability and propose the toxicity-potentiating effects as an important key in linking NMDA-induced endogenous synthesis to acute excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856862     DOI: 10.1002/(SICI)1097-4547(19981215)54:6<787::AID-JNR6>3.0.CO;2-#

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

Review 1.  Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotection.

Authors:  Jessie I Luoma; Christopher M Stern; Paul G Mermelstein
Journal:  J Steroid Biochem Mol Biol       Date:  2011-11-12       Impact factor: 4.292

2.  Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse.

Authors:  T Maurice; V L Phan; A Urani; I Guillemain
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.

Authors:  Ozlem Gursoy Calan; Pinar Akan; Aysenur Cataler; Cumhur Dogan; Semra Kocturk
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

4.  Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key.

Authors:  Philippe Liere; Antoine Pianos; Bernard Eychenne; Annie Cambourg; Karl Bodin; William Griffiths; Michael Schumacher; Etienne-Emile Baulieu; Jan Sjövall
Journal:  J Lipid Res       Date:  2009-06-08       Impact factor: 5.922

5.  Neurosteroids and glutamate toxicity in fibroblasts expressing human NMDA receptors.

Authors:  M Scott; J J Tanguay; R J Beninger; K Jhamandas; R J Boegman
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

6.  Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.

Authors:  P Wong; Y Sze; C C R Chang; J Lee; X Zhang
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.